Form4insider filings, from the source

SEC Form 4 · accession 0001493152-16-012621

Ernexa Therapeutics Inc. · ERNA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Jeffrey Alan Berg
Director · 10% Owner
Period of report
Aug 12, 2016
Accepted (ET)
Aug 17, 2016 · 12:23 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000748592

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Aug 12, 2016P1,000$5.25A414,380ISee Footnote
Common StockF2Aug 12, 2016P1,000$5.45A415,380ISee Footnote
Common StockF2Aug 12, 2016P1,000$5.34A416,380ISee Footnote
Common StockF2Aug 12, 2016P1,000$5.44A417,380ISee Footnote
Common Stockholding———10,600D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses